SPATIAL GENOMICS, INC.

Pasadena, CA · Medtech · Private

GenePS instrument for automated sequential fluorescence in situ hybridization (seqFISH) enabling high-throughput gene expression imaging at single-cell resolution in tissue samples

spatialgenomics.com →
Grants
$17M
14 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Spatial Genomics for in situ single cell expression analysis in the brain$1,181,404
Federal grantDepartment of Health and Human Services · Phase I · Spatial Genomics for in situ single cell expression analysis in the brain$265,936
Federal grantDepartment of Health and Human Services · Phase II · Spatial and single cell analysis of tumor microenvironment by seqFISH+$1,999,998
Federal grantDepartment of Health and Human Services · Phase II · Spatial Genomics for in situ single cell expression analysis in the brain$1,989,076
Federal grantDepartment of Health and Human Services · Phase II · Spatial and single cell analysis of tumor microenvironment by seqFISH+$999,999
Federal grantDepartment of Health and Human Services · Phase II · Spatial Genomics for in situ single cell expression analysis in the brain$994,538
Federal grantDepartment of Health and Human Services · Phase II · Multi-modal spatial genomics in the mouse and human brains$1,337,968
Federal grantDepartment of Health and Human Services · Phase II · Spatial genomics analysis of tumor samples$998,481
Federal grantDepartment of Health and Human Services · Phase II · Spatial single cell analysis of the human Alzheimer's Disease brain$1,229,313
Federal grantDepartment of Health and Human Services · Phase II · Multi-modal spatial genomics in the mouse and human brains$1,337,968
Federal grantDepartment of Health and Human Services · Phase II · Spatial single cell analysis of the human Alzheimer's Disease brain$1,229,313
Federal grantDepartment of Health and Human Services · Phase II · Spatial genomics analysis of tumor samples$998,481
Federal grantDepartment of Health and Human Services · Phase II · Next generation spatial genomics tools for the human brain$1,244,076
Federal grantDepartment of Health and Human Services · Phase II · Next generation spatial genomics tools for the human brain$1,244,076
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1442NANO MEDICINE RESEARCH & DEVELOPMENT LLC——
1443Avalon Med Spa, LLC—$358K
1444Biothea Pharma, Inc.—$22M
1445SPATIAL GENOMICS, INC.——
1446Clear Advantage Collar, Inc.—$360K
1447Obstetrx, Inc.—$1.1M
1448Anuncia Medical, Inc.—$12M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.